How is race utilized, reported and interpreted in biomedical research? Is the use of race as a variable in clinical research practical or problematic? How can researchers responsibly investigate health disparities between racial groups to work towards meaningful change?
In the Spring 2021 installation of the Levy Library’s Research Insider series, we invite you to join us for a seminar that explores these issues from multiple perspectives, including representatives from the funding, publishing, and research communities.
RADM Richardae Araojo, Pharm. D., MS, Associate Commissioner for Minority Health and Director of the Office of Minority Health and Health Equity (OMHHE) in the Office of the Commissioner at the U.S. Food and Drug Administration (FDA)
Emma K. Benn, Dr.PH. MPH, Associate Professor in the Center for Biostatistics and Department of Population Health Science and Policy and Founding Director of the Center for Scientific Diversity at the Icahn School of Medicine at Mount Sinai (ISMMS)
Sri Devi Narasimham, Ph.D. Deputy Editor, Cell, Cell Press
Eliseo J. Pérez-Stable, M.D., Director of the National Institute on Minority Health and Health Disparities (NIMHD) at the National Institutes of Health (NIH)
1- Introduction: Opening Remarks by Rachel Pinotti, MLIS, Assistant Library Director or Education & Research Services, The Levy Library
2- Panelists Presentations
– Eliseo J. Pérez-Stable, M.D.: Race, Ethnicity, Social Class and Racism in Research
– Sri Devi Narasimhan, Ph.D.: Inclusion and Diversity at Cell & Cell Press
– RADM Richardae Araojo, Pharm. D., MS: Reporting and Advancing Clinical Trial Diversity: A Perspective from the FDA Office of Minority Health and Health Equity
– Emma K. T. Benn, DrPH, MPH: Race and causal inference in health disparities research: moving beyond our circular slump
3- Panel Discussion and Q & A
Moderators: Paulos Mengsteab, PhD, MD Candidate, Class of 2023, Icahn School of Medicine at Mount Sinai; Kevin Weiss, MPH, MD Candidate, Class of 2023, Icahn School of Medicine at Mount Sinai
4- Closing remarks